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ICRISAT has adopted the CGIAR IA Principles1 which require that CGIAR Centers carefully consider 
whether to register/apply for (or allow third parties to register/apply for) patents and/or PVP over 
the CGIAR Centers’ respective Intellectual Assets. Under the policy, as a general rule, such 
applications will not be made unless they are necessary for the further improvement of the 
Intellectual Assets or to enhance the scale or scope of impact on target beneficiaries, in furtherance 
of the CGIAR Vision.  This disclosure is in fulfilment of the CGIAR IA Principles to provide justifications 
for the patent applications filed by ICRISAT. 
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Background 
Pigeonpea [Cajanus cajan (L.) Millsp.] is an important grain legume which is globally cultivated in 
more than 6 million hectares in the tropical and sub-tropical regions of the developing countries. The 
dehulled split grains of pigeonpea constitute a major supplement in the diets of a huge proportion of 
the population. In spite of extensive research and development activities, the yield levels have 
remained stagnated in pigeonpea. Hybrid development has contributed immensely to the dramatic 
advances in the quality and quantity of crops produced, which includes combination of desirable 
characteristics. Hybrids exhibit heterosis, whereby the hybrid progeny exhibit superior growth 
characteristics than parental lines.  
 
However, in cases of self-pollinated plants, there is a requirement of manual emasculation, i.e, 
removal of stamens or anthers which results in immense increase in labor cost. Therefore, 
cytoplasmic genetic male sterility (CGMS) systems in plants are being exploited to facilitate 
commercial hybrid seed production because of the following advantages:  
• Avoidance of enormous manual work of emasculation and pollination  
• Potential for large-scale production of F1 seeds  
• Potential for speeding up hybridization program 
 
 
1 https://www.cgiar.org/wp/wp-content/uploads/ 2018/03/CGIAR-IA-Principles.pdf 
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The use of CGMS system in developing hybrids is only possible when effective maintainer lines and 
restorer lines are identified. There are several challenges in identifying fertility restorer lines required 
for the development of fertile hybrid seeds, especially for pigeonpea. Since pigeonpea is an annual 
crop species, it takes two years to identify fertility restorer lines on traditional bases - first, crossing 
known male sterile lines with tester lines and harvest crossed seeds is to be done, followed by the 
field sowing of crossed seeds and subsequently pollen viability test of plant in the second year.  
 
To overcome these costly delays, ICRISAT scientists developed molecular markers that can be used to 
identify/differential fertility restorer lines from non-restorer lines. Once identified through use of the 
markers, the restorer lines can be used immediately, without the need for crossing and phenotyping, 
thereby saving [two years] of time and associated costs.  As part of this invention, ICRISAT scientist 
developed primers (that can be used to amplify genomic segments associated with fertility restoration 
in pigeonpea) for accelerating the process of identification of fertility restorer lines of pigeonpea.  
 
Typically, ICRISAT publishes its molecular markers associated with breeding traits of interest so they 
are available as an international public good. A patent application has been sought exceptionally in 
this instance as they are associated with a restorer lines that comprises of material component of a 
CGMS breeding system over which ICRISAT seeks to secure IP protection on the grounds indicated 
below.  
1. With IP protection on this invention, ICRISAT will make sure the free flow access of this 
invention to the public research  
2. With IP protection on this invention, ICRISAT will attract more private partners in HPRC 
(license can be supplied with no additional cost) and subsequently will enhance their 
confidence in pigeonpea hybrid technology3.  
3. The invention would enable rapid development of hybrids of pigeonpea with enhanced 
traits. Consequently, the invention would have a direct effect on increasing the yield and 
quality of pigeonpea production which would increase the standard of living of farmers 
across the world. Further, the invention would have an impact on improvement in 
nutritional content of food consumed.  
 
Origin of genetic material from which the innovation is derived 
The pigeonpea lines used for the subject invention were acquired by the ICRISAT Genebank prior to 
year 1993 (before the Biodiversity Act was enacted) from India. Also, India’s Biological Diversity Act 
exempts the crops, from amongst those listed in the Annex-I of the ITPGRFA, for the purpose of 
utilization and conservation for research, breeding and training for food and agriculture. 
 
The subject invention involves usage of ICPA 2039 and ICPL 87119 as parental lines of mapping 
population lines  obtained from the ICRISAT Genebank that were used for development of the 
primers.  
The invention is related to molecular markers for the identification of the fertility restorer lines in 
pigeonpea that were selected from the primer sets 1 and 2. One F2 mapping population was 
developed by crossing CMS line (ICPA 2039) with fertility restorer line (ICPL 87119). ICPA 2039 was 
developed by crossing ICPW29, an accession of C. cajanifolius, a wild relative of pigeonpea, and a 
short-duration cultivar ICP 1150, both of them are in-trust materials of Indian origin. ICPL 87119 was 
developed from ICP 1, which is in-trust Indian origin material and in the process ICP 1 was selfed and 
sixth plant was selected, in subsequent year seeds from sixth plant were planted and plant number 1 
was selected to cross with C 11.  
 
The patent on the primers will not restrict the free flow of genetic material which had been used for 
discovery. The patent application does not extend in any way to the use of those lines; only to the 
markers that ICRISAT developed using those lines.  
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Rationale for this patent 
This patent is defensive i.e. to prevent companies from capturing the invention and thus allow 
ICRISAT to keep it open for public use.   
 
As a CGIAR institute, ICRISAT has a responsibility to strengthen the NARS breeding programs. Since 
the hybrid technology in pigeonpea at NARS institutes is still in early stages, sharing this invention with 
them will certainly help to enhance their own efforts to develop new high yielding hybrids, with 
benefits in increased yields, income, food security for farmers.   
 
Dissemination strategy 
The markers will be shared at no additional cost to private sector partners involved in ICRISAT’s 
Hybrid Parents Research Consortium (HPRC), as a complementary tool for developing their own 
breeding program for hybrid development (ICRISAT’s HPRC model is fully compliant with the CGIAR 
IA Principles).  This will enhance the confidence of private sector in pigeonpea hybrid technology and 
would attract more consortium partners. This will, in turn increase the revenue for ICRISAT.  
 
The markers will also be made available to public sector organizations [e.g., Indian Council of 
Agricultural Research (ICAR)] for research and development and for emergency use. 
 
In-line with the strategy on protecting ICRISAT’s research products approved by its Governing Board 
in Sep 2016, ICRISAT is committed to follow a prudent IP protection decision-making process and 
strategic use of IP rights as stated above.  
 
In order to promote accessibility and use of the innovation by third-parties, we have already 
published this invention as a research article entitled “Molecular mapping and inheritance of 
restoration of fertility (Rf) in A4 hybrid system in pigeonpea (Cajanus cajan (L.) Millsp.). Theoretical 
and Applied Genetics 131: 1605–1614. Further as mentioned above this invention can also be 
offered to private sector through HPRC. By providing the access to this invention to public and 
private sectors, efficiency of their breeding programs will increase and subsequently result in high 
yielding hybrids in a short time to the farmers.  
 
Compliance with national laws 
All our existing and proposed activities would strictly be in-line with the Indian Biological Diversity 
Act. We are also seeking approval from the National Biodiversity Authority (NBA), India, as the Act 
states that any person who intends to obtain IPRs for any invention based on any biological resource 
obtained from India has to seek prior approval. Unless and until this approval is submitted to the 
Indian Patent Office, they will not even consider the patent application for examination. In addition, 
the NBA approval and Patent Grant would trigger the specific ABS compliance requirements.  
ICRISAT adheres to these requirements completely.  
 
